These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12192726)

  • 1. [Huntington's disease, towards the end of neuronal death?].
    Girault V
    Presse Med; 2002 Jul; 31(25):1155. PubMed ID: 12192726
    [No Abstract]   [Full Text] [Related]  

  • 2. The differential susceptibility of specific neuronal populations: insights from Huntington's disease.
    Mitchell IJ; Griffiths MR
    IUBMB Life; 2003 Jun; 55(6):293-8. PubMed ID: 12938730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt is altered in an animal model of Huntington's disease and in patients.
    Colin E; Régulier E; Perrin V; Dürr A; Brice A; Aebischer P; Déglon N; Humbert S; Saudou F
    Eur J Neurosci; 2005 Mar; 21(6):1478-88. PubMed ID: 15845076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demise of a neuronal population in Huntington's disease and the importance of hyponeuronogenesis.
    Kremer HP; Kremer GH
    Clin Neurol Neurosurg; 1992; 94 Suppl():S7-8. PubMed ID: 1320524
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
    Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
    Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calretinin interacts with huntingtin and reduces mutant huntingtin-caused cytotoxicity.
    Dong G; Gross K; Qiao F; Ferguson J; Callegari EA; Rezvani K; Zhang D; Gloeckner CJ; Ueffing M; Wang H
    J Neurochem; 2012 Nov; 123(3):437-46. PubMed ID: 22891683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline in phenotypic models of Huntington's disease.
    Bantubungi K; Jacquard C; Greco A; Pintor A; Chtarto A; Tai K; Galas MC; Tenenbaum L; Déglon N; Popoli P; Minghetti L; Brouillet E; Brotchi J; Levivier M; Schiffmann SN; Blum D
    Neurobiol Dis; 2005 Feb; 18(1):206-17. PubMed ID: 15649711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease: getting closer.
    Greenamyre JT
    Am J Psychiatry; 2007 Sep; 164(9):1318. PubMed ID: 17728414
    [No Abstract]   [Full Text] [Related]  

  • 10. Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease.
    Nana AL; Kim EH; Thu DC; Oorschot DE; Tippett LJ; Hogg VM; Synek BJ; Roxburgh R; Waldvogel HJ; Faull RL
    J Huntingtons Dis; 2014; 3(1):45-64. PubMed ID: 25062764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases.
    Kenchappa P; Yadav A; Singh G; Nandana S; Banerjee K
    J Neurosci Res; 2004 May; 76(4):466-74. PubMed ID: 15114618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease.
    Caviness VS
    Dev Med Child Neurol; 1985 Dec; 27(6):826-9. PubMed ID: 2936639
    [No Abstract]   [Full Text] [Related]  

  • 13. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.
    Keene CD; Rodrigues CM; Eich T; Linehan-Stieers C; Abt A; Kren BT; Steer CJ; Low WC
    Exp Neurol; 2001 Oct; 171(2):351-60. PubMed ID: 11573988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one-hit model of cell death in inherited neuronal degenerations.
    Clarke G; Collins RA; Leavitt BR; Andrews DF; Hayden MR; Lumsden CJ; McInnes RR
    Nature; 2000 Jul; 406(6792):195-9. PubMed ID: 10910361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease.
    Mastroberardino PG; Iannicola C; Nardacci R; Bernassola F; De Laurenzi V; Melino G; Moreno S; Pavone F; Oliverio S; Fesus L; Piacentini M
    Cell Death Differ; 2002 Sep; 9(9):873-80. PubMed ID: 12181738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntingtin and its role in neuronal degeneration.
    Li SH; Li XJ
    Neuroscientist; 2004 Oct; 10(5):467-75. PubMed ID: 15359012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 In vivo.
    Kermer P; Klöcker N; Labes M; Bähr M
    J Neurosci; 2000 Jan; 20(2):2-8. PubMed ID: 10632601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Herrenhausen symposium on neurodegeneration. Forward.
    Nat Med; 2010 Nov; 16(11):1200. PubMed ID: 21052072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.